SS
ORKA

SBI Securities’s Oruka Therapeutics ORKA Stock Holding History

SBI Securities’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33K Buy
+35
New +$2.33K ﹤0.01% 2358
2025
Q4 		– Sell
-6
Closed -$115 – 4267
2025
Q3 		$115 Buy
6
+4
+200% +$59 ﹤0.01% 3478
2025
Q2 		$22 Buy
+2
New +$21 ﹤0.01% 3902

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SBI Securities's ORKA Position: Q2 2026 in Review

SBI Securities opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 35 shares worth $3.33K. The stake represents ﹤0.01% of the portfolio and ranks #2358 among its holdings. This is a return to the name: SBI Securities previously reported a position in ORKA as recently as Q3 2025.

SBI Securities first reported a position in ORKA in Q2 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • SBI Securities held 35 shares of Oruka Therapeutics worth $3.33K as of Q2 2026.
  • Oruka Therapeutics was a new SBI Securities position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2358 holding.
  • SBI Securities first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.